Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. ETF
  3. IBRX
IBRX logo

IBRX

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

IBRX News

Anktiva's New Data Sparks Attention Amid Psychedelic Push

14h agostocktwits

Class Action Lawsuit Filed Against ImmunityBio, Inc.

1d agoGlobenewswire

ImmunityBio Securities Class Action Reminder

1d agoGlobenewswire

Vertex Pharmaceuticals Stock Performance Strong

2d agoCNBC

Reminder of ImmunityBio Securities Class Action

2d agoPRnewswire

Lowey Dannenberg Investigates ImmunityBio for Potential Securities Violations

2d agoGlobenewswire

ImmunityBio Faces Class Action Lawsuit Over Misleading Statements

3d agoGlobenewswire

ImmunityBio Faces Class Action Lawsuit Reminder

3d agoGlobenewswire

ImmunityBio Faces Securities Class Action Lawsuit

3d agoPRnewswire

ImmunityBio Securities Class Action Reminder

3d agoGlobenewswire

ImmunityBio Faces Securities Class Action Lawsuit Over Misleading Claims

3d agoGlobenewswire

Multiple Companies Face Class Action Lawsuits

4d agoGlobenewswire

ImmunityBio Securities Class Action Reminder

4d agoGlobenewswire

ImmunityBio Faces Securities Fraud Class Action Lawsuit

4d agoGlobenewswire

ImmunityBio Shareholder Class Action Filed Over Securities Misrepresentation

4d agoGlobenewswire

ImmunityBio Faces Class Action Lawsuit Over Misleading Claims

4d agoPRnewswire